Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26F80LE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,104
Award facts
- Contract value 100% obligated
- $15,104.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,104.32 delivery order to Amerisourcebergen Drug Corp on July 9, 2026, for Renflexis 100 mg vials, with ultimate completion by July 10, 2026.
The order is issued under a Defense Logistics Agency single-award indefinite delivery contract (SPE2DX) supporting the Pharmaceutical Prime Vendor Global Program Generation V, valued at $4.999 million through December 2036. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside used.
Quick answers
Who was awarded contract SPE2DR26F80LE?
SPE2DR26F80LE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 9, 2026.
How much is contract SPE2DR26F80LE worth?
The government has obligated $15,104 on SPE2DR26F80LE.
Is contract SPE2DR26F80LE an order under another contract?
Yes. SPE2DR26F80LE is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F80LE competed?
The extent of competition for SPE2DR26F80LE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award